(redirected from Symmetric Dimethylarginine)
SDMASpace Division Multiple Access
SDMASan Diego Museum of Art (California)
SDMASpatial Division Multiple Access
SDMASymmetric Dimethylarginine
SDMASedgwick, Detert, Moran & Arnold (law firm; California)
SDMASeattle Direct Marketing Association (Seattle, WA)
SDMASteel Dragons Martial Arts (Beaver Falls, PA)
SDMAStorage Device Migration Aid
SDMASwedish Defence Materiel Administration
SDMASiple Dome A
SDMASerial Direct Memory Access
SDMASwaps and Derivatives Market Association
SDMASecond Marine Division Association
SDMASmallTalk Distributed Messaging Architecture
SDMASlave Direct Memory Access
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Symmetric dimethylarginine and ADMA levels were statistically higher in advanced CKD (eGFR <30 mL/min) for active disease and in remission.
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Boggess et al., "Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs," Journal of Veterinary Internal Medicine, vol.
Schweighauser et al., "Plasma Symmetric Dimethylarginine Concentration in Dogs with
van Leeuwen, "Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography," Analytical Biochemistry, vol.
Bode-Boger, "Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation," Journal of Chromatography B, vol.
[7] Nonstandard abbreviations: iNOS, inducible nitric oxide synthase; Arg1, arginase 1; ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; PRMT, protein methyltransferase; eNOS, endothelial nitric oxide synthase; nNOS, neuronal nitric oxide synthase; DDAH, dimethylarginine diaminohydrolase; HILIC, hydrophilic liquid interaction liquid chromatography; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LPS, lipopolysacharide; [E.sub.2], 17[beta]-estradiol; CRP, C-reactive protein; LOQ, limit of quantification; hsCRP, high-sensitivity CRP.
Group 2 received saline solution, group 3 received 200 mg/kg/day vitamin C (tumour +vit C), group 4 received 300 mg/kg/day vitamin E (tumour +vitE) and group 5 received both 200 mg/kg/day vitamin C and 300 mg/kg/day vitamin E (tumour +vit C+vit E) for 15 days intra-peritoneally.Arginine, asymmetric dimethylarginine, symmetric dimethylarginine and nitric oxide levels were determined in each group.
APACHE: Acute Physiology and Chronic Health Evaluation; BMI: body mass index; CRP: C-reactive protein; ICU: intensive care unit; INR: international normalized ratio; SDMA: symmetric dimethylarginine; SOFA: sequential organ failure assessment; WBC: white blood cell count.
[1] Nonstandard abbreviations: ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; eNOS, endothelial nitric oxide synthase; IS, internal standard; ESI, electrospray; MS/MS, tandem mass spectrometry; and TFA, trifluoroacetic acid.
Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. Diabetes Care 2009; 32:2084-2086.